Sarah Castledine
0161 259 7053

Acquisition Opportunity - Accelerated Process

Agents for this sale:

Sarah Castledine
0161 259 7053

Project X
Opportunity to Acquire a Portfolio of Life Science Patents
Expressions of Interest are to be submitted as soon as possible

    An opportunity has arisen to acquire a portfolio of patents for the treatment of cancer. It is anticipated that the purchase will take the form of the patent portfolio in specie or the patent portfolio together with the UK company that holds them.


    All interested parties will be required to sign a non-disclosure agreement and have the ability to work to the following timeline:
    Expressions of interest are to be submitted as soon as possible;
    Indicative offers are to be submitted by 7 June 2019
    Final and fully funded offers to follow by 21 June 2019 and
    Completion of the purchase is to be executed shortly thereafter, but in any event before 30 June 2019.


    This document has been prepared by Smith & Williamson LLP (S&W) on behalf of the seller. It is intended only as a brief outline on the business to enable parties to establish whether the opportunity outlined might be of interest to them.
    The information set out above has been provided by the seller and not audited, verified or warranted by S&W and therefore no guarantee as to the accuracy of the information can be given. No liability is accepted for any loss, cost or damage suffered or incurred as a result of reliance on such information. S&W will not give any advice to any recipient of this document.


    Emma O'Bryan, tel: 020 7131 8420, emma.obryan@smithandwilliamson.com or
    Adam Stephens, tel: 020 7131 4540, adam.stephens@smithandwilliamson.com
    Both c/o Smith & Williamson LLP, 25 Moorgate, London, EC2R 6AY

Link: A-5767596

Sign up to our mailing list

RICS CCS TDS Arla Ombudsman bsi